Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Statin-associated myopathy is characterized by which of the following?

Statin-associated myopathy shows up as muscle symptoms—such as pain, cramps, or weakness—in people taking statins, with evidence of muscle injury on testing, most commonly an elevated creatine kinase. The CK rise indicates damage to muscle fibers caused by the statin, so when patients report muscle symptoms and CK is elevated, it points to myopathy. Sometimes weakness or myalgia can occur even if CK is not dramatically high, but the combination of muscle symptoms with CK elevation or functional weakness remains the defining pattern. The other scenarios describe issues that are not typical of statin-related muscle injury—nerve-related numbness without enzyme change, liver pain without CK changes, or simply a lipid change profile that isn’t the hallmark of myopathy.

Statin-associated myopathy shows up as muscle symptoms—such as pain, cramps, or weakness—in people taking statins, with evidence of muscle injury on testing, most commonly an elevated creatine kinase. The CK rise indicates damage to muscle fibers caused by the statin, so when patients report muscle symptoms and CK is elevated, it points to myopathy. Sometimes weakness or myalgia can occur even if CK is not dramatically high, but the combination of muscle symptoms with CK elevation or functional weakness remains the defining pattern. The other scenarios describe issues that are not typical of statin-related muscle injury—nerve-related numbness without enzyme change, liver pain without CK changes, or simply a lipid change profile that isn’t the hallmark of myopathy.